|Bid||0.00 x 1400|
|Ask||0.00 x 800|
|Day's range||118.75 - 122.74|
|52-week range||91.87 - 142.64|
|Beta (5Y monthly)||1.34|
|PE ratio (TTM)||38.04|
|Earnings date||31 Jan 2022 - 04 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||159.42|
Catalent (CTLT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
SOMERSET, N.J., November 23, 2021--Catalent, Inc. (NYSE: CTLT), the global leader in enabling pharma, biotech, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that members of its executive leadership team will virtually present at the Stephens Annual Investment Conference at 11:00 a.m. ET on November 29, 2021.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.